Holdings (Monthly)
Guide ↗
iShares Genomics Immunology and Healthcare ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | Apr 2024 | 19,834,626 | -3,783,518 | $19.8M | -16.1% | 10.39% | STIV |
| 2 | Bayer Aktiengesellschaft | N/A | Jan 2026 | 165,508 | +128,341 | $9.2M | +51.3% | 4.81% | EC |
| 3 | Twist Bioscience Corp | 90184D100 | Apr 2024 | 99,937 | +9,702 | $9.1M | +146.9% | 4.79% | EC |
| 4 | REVOLUTION MEDICINES, INC. | 76155X100 | Apr 2024 | 46,352 | -19,912 | $8.7M | +35.3% | 4.55% | EC |
| 5 | REGENERON PHARMACEUTICALS, INC. | 75886F107 | Apr 2024 | 10,887 | +3,541 | $8.3M | +52.4% | 4.35% | EC |
| 6 | GENMAB A/S | N/A | Jan 2026 | 28,069 | NEW | $8.1M | — | 4.23% | EC |
| 7 | INCYTE CORPORATION | 45337C102 | Apr 2024 | 67,570 | +16,095 | $8.1M | +56.8% | 4.23% | EC |
| 8 | MODERNA, INC. | 60770K107 | Apr 2024 | 145,819 | -44,695 | $8.0M | -4.8% | 4.19% | EC |
| 9 | Takeda Pharmaceutical Company Limited | N/A | Jan 2026 | 225,100 | NEW | $7.7M | — | 4.05% | EC |
| 10 | MERCK & CO., INC. | 58933Y105 | Apr 2024 | 57,270 | +4,349 | $7.5M | +27.8% | 3.91% | EC |
| 11 | VERTEX PHARMACEUTICALS INCORPORATED | 92532F100 | Jan 2026 | 15,481 | +3,895 | $7.4M | +35.7% | 3.87% | EC |
| 12 | Roche Holding AG | N/A | Jan 2026 | 16,796 | NEW | $7.3M | — | 3.85% | EC |
| 13 | IPSEN SA | N/A | Jan 2026 | 37,928 | NEW | $7.3M | — | 3.84% | EC |
| 14 | BioNTech SE | 09075V102 | Apr 2024 | 78,540 | +23,712 | $7.1M | +14.1% | 3.73% | — |
| 15 | EXELIXIS, INC. | 30161Q104 | Apr 2024 | 131,275 | +12,311 | $7.0M | +41.5% | 3.65% | EC |
| 16 | GSK PLC | N/A | Jan 2026 | 266,670 | NEW | $6.9M | — | 3.63% | EC |
| 17 | SANOFI SA | N/A | Jan 2026 | 76,788 | NEW | $6.6M | — | 3.46% | EC |
| 18 | IDEAYA Biosciences Inc | 45166A102 | Jan 2026 | 180,483 | +50,748 | $6.4M | +53.4% | 3.36% | EC |
| 19 | Immunitybio Inc | 45256X103 | Apr 2024 | 817,183 | +303,853 | $5.9M | +82.6% | 3.07% | EC |
| 20 | ARCUS BIOSCIENCES, INC. | 03969F109 | Apr 2024 | 181,763 | +65,775 | $5.1M | +110.0% | 2.68% | EC |
| 21 | CARIS LIFE SCIENCES, INC. | 142152107 | Jan 2026 | 266,135 | +87,576 | $4.2M | +0.8% | 2.18% | EC |
| 22 | ONO PHARMACEUTICAL CO., LTD. | N/A | Jan 2026 | 244,500 | NEW | $3.7M | — | 1.91% | EC |
| 23 | Iovance Biotherapeutics Inc | 462260100 | Apr 2024 | 841,830 | +327,164 | $3.4M | +161.1% | 1.80% | EC |
| 24 | NUVATION BIO INC. | 67080N101 | Jan 2026 | 536,281 | +165,879 | $3.4M | +74.9% | 1.78% | EC |
| 25 | CRISPR Therapeutics AG | H17182108 | Jan 2026 | 62,247 | +14,206 | $3.0M | +24.5% | 1.57% | EC |
| 26 | ABCELLERA BIOLOGICS INC. | 00288U106 | Apr 2024 | 508,935 | +151,057 | $2.9M | +124.3% | 1.52% | EC |
| 27 | Vir Biotechnology Inc | 92764N102 | Apr 2024 | 289,265 | +144,324 | $2.5M | +132.3% | 1.31% | EC |
| 28 | NOVAVAX, INC. | 670002401 | Apr 2024 | 339,643 | +110,253 | $2.5M | +22.5% | 1.30% | EC |
| 29 | Janux Therapeutics Inc | 47103J105 | Jan 2026 | 124,166 | +41,051 | $1.9M | +65.3% | 0.99% | EC |
| 30 | Sunshine Lake Pharma Co Ltd | Y8243F109 | Jan 2026 | 351,500 | +185,600 | $1.9M | +107.3% | 0.98% | EC |
| 31 | Corvus Pharmaceuticals Inc | 221015100 | Jan 2026 | 137,099 | +48,199 | $1.8M | -1.2% | 0.95% | EC |
| 32 | Personalis Inc | 71535D106 | Jan 2026 | 134,479 | +52,103 | $1.7M | +120.6% | 0.89% | EC |
| 33 | Kura Oncology Inc | 50127T109 | Jan 2026 | 186,448 | +56,042 | $1.7M | +58.6% | 0.88% | EC |
| 34 | GenFleet Therapeutics (Shanghai) Inc | Y2S2YD109 | Jan 2026 | 419,200 | +118,400 | $1.5M | +25.3% | 0.78% | EC |
| 35 | RIGEL PHARMACEUTICALS, INC. | 766559702 | Jan 2026 | 38,807 | +11,386 | $1.4M | +49.4% | 0.75% | EC |
| 36 | CytomX Therapeutics Inc | 23284F105 | Jan 2026 | 375,908 | +177,482 | $1.2M | +3.2% | 0.61% | EC |
| 37 | VERASTEM, INC. | 92337C203 | Jan 2026 | 178,719 | +78,209 | $1.0M | +69.1% | 0.54% | EC |
| 38 | Alvotech SA | L01800108 | Jan 2026 | 244,900 | +80,984 | $1.0M | +14.6% | 0.53% | EC |
| 39 | Design Therapeutics Inc | 25056L103 | Jan 2026 | 81,808 | +33,288 | $996K | +101.1% | 0.52% | EC |
| 40 | Xencor Inc | 98401F105 | Apr 2024 | 48,671 | +13,305 | $984K | +130.1% | 0.52% | EC |
| 41 | INTELLIA THERAPEUTICS, INC. | 45826J105 | Apr 2024 | 91,888 | +33,943 | $981K | +28.8% | 0.51% | EC |
| 42 | Shanghai Henlius Biotech Inc | N/A | Jan 2026 | 135,900 | NEW | $964K | — | 0.51% | EC |
| 43 | OCUGEN, INC. | 67577C105 | Jan 2026 | 723,783 | +246,346 | $890K | +28.6% | 0.47% | EC |
| 44 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 69404D108 | Jan 2026 | 622,048 | +204,492 | $871K | -7.7% | 0.46% | EC |
| 45 | VALNEVA SE | N/A | Jan 2026 | 349,239 | NEW | $866K | — | 0.45% | EC |
| 46 | Ginkgo Bioworks Holdings Inc | 37611X209 | Jan 2026 | 101,324 | +35,808 | $820K | +39.5% | 0.43% | EC |
| 47 | AbClon Inc. | Y0R0KQ104 | Jan 2026 | 34,319 | +10,799 | $470K | -54.5% | 0.25% | EC |
| 48 | Prime Medicine, Inc | 74168J101 | Jan 2026 | 65,480 | +16,016 | $191K | +1.5% | 0.10% | EC |
| 49 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 066922477 | Apr 2024 | 177,863 | +100,320 | $178K | +129.4% | 0.09% | STIV |
| 50 | JAPANESE YEN | N/A | Jan 2026 | 11,386,897 | NEW | $72K | — | 0.04% | — |
| 51 | GREAT BRITISH POUND | N/A | Jan 2026 | 43,296 | NEW | $58K | — | 0.03% | — |
| 52 | XAV HEALTH CARE SEP26 | 1XAVU26 | Jan 2026 | 3 | NEW | $26K | — | 0.01% | DE |
| 53 | KOREAN WON | N/A | Jan 2026 | 21,182,477 | NEW | $15K | — | 0.01% | — |
| 54 | DANISH KRONER | N/A | Jan 2026 | 88,953 | NEW | $14K | — | 0.01% | — |
| 55 | ARCELLX INC CVR | 039CVR014 | Jul 2026 | 73,059 | NEW | $5K | — | 0.00% | EC |
| 56 | HONG KONG DOLLAR | N/A | Jan 2026 | 28,855 | NEW | $4K | — | 0.00% | — |
| 57 | SWISS FRANC | N/A | Jan 2026 | 696 | NEW | $860 | — | 0.00% | — |
| 58 | EURO | N/A | Jan 2026 | 662 | NEW | $763 | — | 0.00% | — |
| 59 | NEW TAIWAN DOLLAR | N/A | Jan 2026 | 5,229 | NEW | $162 | — | 0.00% | — |
| 60 | OMNIAB INC | 68218J202 | Apr 2024 | 19,498 | — | $0 | +0.0% | 0.00% | EC |
| 61 | OMNIAB INC | 68218J301 | Apr 2024 | 19,498 | — | $0 | +0.0% | 0.00% | EC |
| ✕ | Arcellx Inc | 03940C100 | — | 66,953 | SOLD | $4.6M | — | — | — |
| ✕ | Guangzhou Innogen Pharmaceutical Group Co Ltd | Y293B9102 | — | 104,600 | SOLD | $0.4M | — | — | — |
| ✕ | Mereo BioPharma Group PLC | 589492107 | — | 213,432 | SOLD | $0.1M | — | — | — |